Emphysematous pyelonephritis: Difference between revisions

(Text replacement - " ampicillin " to " ampicillin ")
 
(7 intermediate revisions by 3 users not shown)
Line 1: Line 1:
==Background==
==Background==
[[File:Blausen 0592 KidneyAnatomy 01.png|thumb|Renal anatomy.]]
*Rare gas-forming infection nearly always occurring in patients with [[DM]] and obstruction
*Rare gas-forming infection nearly always occurring in patients with [[DM]] and obstruction
**Patients appear toxic and [[septic]]; nephrectomy may be required
**Patients appear toxic and [[septic]]; nephrectomy may be required
{{UTI types}}


==Clinical Features<ref> Tang HJ, et al. Clinical characteristics of emphysematous pyelonephritis. J Microbiol Immunol Infect. 2001 Jun. 34(2):125-30. </ref>==
==Clinical Features<ref> Tang HJ, et al. Clinical characteristics of emphysematous pyelonephritis. J Microbiol Immunol Infect. 2001 Jun. 34(2):125-30. </ref>==
Line 9: Line 12:
*[[Nausea/vomiting]]
*[[Nausea/vomiting]]
*[[Dyspnea]]
*[[Dyspnea]]
*Renal dysfunction
*[[AKI|Renal dysfunction]]
*[[Altered mental status]]
*[[Altered mental status]]
*[[Shock]]
*[[Shock]]
Line 18: Line 21:


==Evaluation==
==Evaluation==
[[File:PMC4421217 sfn002fig2.png|thumb|Axial CT scan image of left kidney reveals emphysematous pyelonephritis.]]
===Labs===
===Labs===
*CBC with high WBC, low platelets
*CBC with [[leukocytosis|high WBC]], [[thrombocytopenia|low platelets]]
*UA with urine culture
*[[Urinalysis]] with urine culture
*Creatinine
*Creatinine
*Blood culture
*Blood culture
Line 31: Line 35:
**Class 3A - perinephric extension of gas or abscess
**Class 3A - perinephric extension of gas or abscess
**Class 3B - extension of gas beyond Gerota fascia
**Class 3B - extension of gas beyond Gerota fascia
**Class 4 - b/l or EPN in solitary kidney
**Class 4 - bilateral or EPN in solitary kidney


==Management==
==Management==
*IVF
*[[IVF]]
*Antibiotics
*Antibiotics
**IV ampicillin, gentamicin, metronidazole
**IV [[ampicillin]], [[gentamicin]], [[metronidazole]]
**Vancomycin in place of [[ampicillin]] for pcn allergy
**[[Vancomycin]] in place of [[ampicillin]] for penicillin allergy


==Disposition<ref>Shetty S et al. Emphysematous Pyelonephritis Treatment & Management. eMedicine. Apr 11, 2014. http://emedicine.medscape.com/article/457306-treatment#showall.</ref>==
==Disposition<ref>Shetty S et al. Emphysematous Pyelonephritis Treatment & Management. eMedicine. Apr 11, 2014. http://emedicine.medscape.com/article/457306-treatment#showall.</ref>==
Line 58: Line 62:
[[Category:Renal]]
[[Category:Renal]]
[[Category:Urology]]
[[Category:Urology]]
[[Category:ID]]

Latest revision as of 07:11, 6 January 2022

Background

Renal anatomy.
  • Rare gas-forming infection nearly always occurring in patients with DM and obstruction
    • Patients appear toxic and septic; nephrectomy may be required

Genitourinary infection

(1) Human urinary system: (2) kidney; (3) renal pelvis; (4) ureter; (5) urinary bladder (6) urethra.
Additional structures: (7) adrenal gland; (8) renal artery and vein; (9) inferior vena cava; (10) abdominal aorta; (11) common iliac artery and vein; (12) liver; (13) large intestine; (14) pelvis.

"UTI" frequently refers specifically to acute cystitis, but may also be used as a general term for all urinary infections; use location-specific diagnosis.

Clinical Features[1]

Differential Diagnosis

Dysuria

Evaluation

Axial CT scan image of left kidney reveals emphysematous pyelonephritis.

Labs

Imaging

  • CT is definitive
  • Staging[2]:
    • Class 1 - gas confined to collecting system
    • Class 2 - gas confined to renal parenchyma alone
    • Class 3A - perinephric extension of gas or abscess
    • Class 3B - extension of gas beyond Gerota fascia
    • Class 4 - bilateral or EPN in solitary kidney

Management

Disposition[3]

  • Poor prognostic risk factors:
    • Creatinine > 1.4mg/dL
    • Platelets < 60k
    • Altered mental status
    • Shock
  • Urological consult for percutaneous drainage, stent placement, or nephrectomy (classes 3 and 4 with 2 or more prognostic risk factors)
  • Presence of obstructive stone requires even more urgent surgical intervention
  • Mortality rates between ~20-40%

See Also

External Links

References

  1. Tang HJ, et al. Clinical characteristics of emphysematous pyelonephritis. J Microbiol Immunol Infect. 2001 Jun. 34(2):125-30.
  2. Huang JJ, Tseng CC. Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med. 2000 Mar 27. 160(6):797-805.
  3. Shetty S et al. Emphysematous Pyelonephritis Treatment & Management. eMedicine. Apr 11, 2014. http://emedicine.medscape.com/article/457306-treatment#showall.